Aminophyllin and Duodenal ulcer aggravated - a phase IV clinical study of FDA data

Summary:

Duodenal ulcer aggravated is reported as a side effect among people who take Aminophyllin (aminophylline), especially for people who are male, 60+ old, also take Furosemide, and have Oropharyngeal discomfort.

The phase IV clinical study analyzes which people have Duodenal ulcer aggravated when taking Aminophyllin. It is created by eHealthMe based on reports of 3,088 people who have side effects when taking Aminophyllin from the FDA, and is updated regularly.

What is Aminophyllin?

Aminophyllin has active ingredients of aminophylline. eHealthMe is studying from 3,118 Aminophyllin users. Check the latest studies of Aminophyllin.

What is Duodenal ulcer aggravated?

Duodenal ulcer aggravated is found to be associated with 1,477 drugs and 523 conditions by eHealthMe. Check the latest studies of Duodenal ulcer aggravated.

On Jul, 03, 2026

3,088 people reported to have side effects when taking Aminophyllin.
Among them, 25 people (0.81%) have Duodenal ulcer aggravated.

Could Aminophyllin cause Duodenal ulcer aggravated?

Among these 25 people:

What is the gender of people who have Duodenal ulcer aggravated when taking Aminophyllin? *

female: 12 %
male: 88 %

What is the age of people who have Duodenal ulcer aggravated when taking Aminophyllin? *

What are other drugs people take besides Aminophyllin? *

Lansoprazole: 12 people, 48.00%
Prednisolone: 12 people, 48.00%
Furosemide: 12 people, 48.00%
Gliclazide: 11 people, 44.00%
Primidone: 11 people, 44.00%
Fluticasone Propionate: 10 people, 40.00%
Adalat: 10 people, 40.00%
Tolterodine Tartrate: 10 people, 40.00%
Alendronic Acid: 6 people, 24.00%
Morphine: 5 people, 20.00%

What are other side effects people have besides Duodenal ulcer aggravated? *

Weight Decreased: 11 people, 44.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 44.00%
Gastritis (inflammation of stomach): 11 people, 44.00%
Oesophageal Ulcer (ulcer of oesophagus): 11 people, 44.00%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 5 people, 20.00%
Anaemia (lack of blood): 4 people, 16.00%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 16.00%
Nausea (feeling of having an urge to vomit): 4 people, 16.00%
Nausea And Vomiting: 4 people, 16.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 12.00%

What are the existing conditions these people have? *

Urine Output - Decreased: 4 people, 16.00%
Insomnia (sleeplessness): 4 people, 16.00%
Cancer Pain: 4 people, 16.00%
Constipation: 4 people, 16.00%
Fever: 4 people, 16.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 16.00%
High Blood Pressure: 4 people, 16.00%
Oropharyngeal Discomfort (pain or irritation of oropharynx): 4 people, 16.00%
Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 12.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aminophyllin and have Duodenal ulcer aggravated?

- Check whether Duodenal ulcer aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminophyllin:

Aminophyllin (3,118 reports)

Browse all side effects of Aminophyllin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Duodenal ulcer aggravated:

Duodenal ulcer aggravated (1,477 drugs)

Browse all the conditions that are associated with Duodenal ulcer aggravated:

Duodenal ulcer aggravated (523 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminophylline (the active ingredients of Aminophyllin) and Aminophyllin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.